# Incidental finding of a DMD exons 48–55 deletion during prenatal diagnosis

## TL;DR

A rare DMD gene deletion was found during prenatal testing, showing that some genetic changes may not cause symptoms.

## Contribution

First report of a DMD exons 48–55 deletion identified in prenatal diagnosis.

## Key findings

- The deletion spans DMD exons 48–55 and is located at chrX:31640088–31945085.
- The male with the deletion had normal serum biochemical indicators and no symptoms.
- This case highlights the variability of DMD phenotypes and the need for cautious interpretation of genetic findings.

## Abstract

DMD genetic variants cause a spectrum of phenotypes, from severe progressive proximal muscle weakness and degeneration leading to wheelchair dependence and death from cardiac and/or respiratory failure to very mild muscular phenotypes; very rarely, cases are completely asymptomatic. Few cases have been reported in males carrying DMD deletions who are asymptomatic.

Family clinical information was collected from the patients. A single nucleotide polymorphism array (SNP-array) was used to detect abnormalities in prenatal diagnosis, and multiplex ligation-dependent probe amplification (MLPA) and long-read sequencing (LRS) were used to confirm the detected variant.

We incidentally identified DMD exons 48–55 deletion using SNP-array in prenatal diagnosis; the variant was confirmed using MLPA and LRS, and the fragment size and precise locations of breakpoints were determined. The variant was precisely located at genomic position chrX:31640088–31945085, spanning from intron 47 to intron 56 in DMD. Serum biochemical indicators were normal in the male with the deletion.

Our study is the first to report a DMD exons 48–55 deletion in prenatal diagnosis. The phenotypes of DMD variants are diverse, and this study suggests that prediction of clinical severity based solely on molecular findings should be interpreted with caution.